When most individuals contemplate dementia, a singular mental picture typically emerges. The condition, impacting approximately seven million Americans, is predominantly characterised by memory problems, forgetfulness, and gradual personality alterations. Alzheimer's disease, representing the most prevalent form, accounts for roughly sixty percent of all dementia cases. Other variants that have garnered increased attention in recent years include frontotemporal dementia, as experienced by actor Bruce Willis, alongside Lewy Body dementia and vascular dementia.
The Broad Spectrum of Dementia
However, dementia serves as an overarching term referring to more than one hundred distinct subtypes. These forms do not invariably provoke stereotypical memory loss and can prove significantly more challenging to diagnose accurately. Creutzfeldt-Jakob disease (CJD), for instance, while exceptionally rare, possesses a one hundred percent fatality rate and typically proves fatal within mere months. Although memory deterioration does occur progressively, patients may initially notice balance disturbances and involuntary jerking movements. Furthermore, about fifteen percent of individuals diagnosed with frontotemporal dementia may subsequently develop the fatal neurological condition ALS.
Four Under-Recognised Dementia Subtypes
Presented below are detailed profiles of four dementia subtypes that frequently evade immediate recognition, alongside the critical signs and symptoms warranting vigilance.
Posterior Cortical Atrophy
Posterior cortical atrophy (PCA), also identified as Benson's syndrome, constitutes a dementia type distinguished by degeneration of the brain's outermost, wrinkled layer of grey matter. This layer, termed the cerebral cortex, governs high-level functions including consciousness, thought, emotion, memory, language, and sensory processing.
Damage to the cerebral cortex can precipitate severe visual processing impairments, such as reading difficulties and compromised depth perception, rather than early-stage memory lapses. Additional symptoms encompass trouble recognising familiar objects and faces, blurred vision, navigation challenges, and problems locating items within the home environment.
As PCA advances, patients might encounter anxiety, difficulties with basic arithmetic, hallucinations, and eventual memory issues. Researchers remain uncertain whether PCA represents its own distinct dementia form or a variant of Alzheimer's disease. The disease often involves plaques of toxic amyloid proteins, analogous to Alzheimer's, but situated within the cerebral cortex instead of the hippocampus.
While Alzheimer's most commonly manifests after age sixty-five, PCA typically emerges between ages fifty and sixty-five. Due to the absence of specific diagnostic criteria for PCA, precise prevalence figures remain unclear, according to the Alzheimer's Association. Some studies estimate PCA affects five percent of individuals with Alzheimer's, but the Association notes the true proportion could reach fifteen percent, given frequent under-recognition.
The underlying causes of PCA are presently unknown, with no identified genetic mutations associated. Furthermore, no treatments have been specifically designed to address PCA.
Creutzfeldt-Jakob Disease
Creutzfeldt-Jakob disease (CJD) represents an exceptionally rare dementia form, affecting an estimated three hundred fifty to five hundred Americans annually, equating to approximately one in one million people globally.
The disease arises when proteins known as prions, for reasons yet unknown, misfold. Instead of assuming correct configurations, they morph into aberrant three-dimensional shapes and accumulate within the brain, precipitating rapid dementia development.
Symptoms include swiftly worsening confusion, disorientation, memory loss, and impaired judgment, alongside balance issues, stiff movements, and involuntary jerking or twitching. Patients may also experience blurred vision, depression, anxiety, slurred speech, and insomnia.
CJD is invariably fatal. Whereas typical dementia usually requires years to prove lethal, CJD typically culminates in death within a few months to a year. Patients generally succumb to secondary complications such as swallowing difficulties, heart and lung failure, or pneumonia.
In extremely rare instances, CJD has been associated with consuming meat from animals afflicted with chronic wasting disease. However, approximately eighty-five percent of cases are sporadic, with no identifiable cause. Given most cases are random, experts struggle to pinpoint specific risk factors, though being over sixty, having a family history of CJD, or exposure to contaminated tissue via transplants may elevate susceptibility.
FTD-MND
FTD-MND denotes a form of frontotemporal dementia that co-occurs with motor neuron disease (MND), known in the United States as ALS or Lou Gehrig's disease. Frontotemporal dementia (FTD) causes gradual decline in brain regions linked to personality and language capabilities. Both actor Bruce Willis and talk show host Wendy Williams have received diagnoses of this condition.
FTD erodes brain areas controlling language, behaviour, and personality. Unlike Alzheimer's disease, patients do not immediately lose memory but instead undergo significant personality transformations. It also assaults brain regions responsible for judgment, impulse control, and decision-making, rendering patients vulnerable to financial mismanagement.
FTD accounts for roughly one in twenty dementia cases, totalling approximately fifty thousand to sixty thousand Americans. Experts estimate ten to fifteen percent of individuals with FTD also develop ALS, which has been linked to mutations in the C9orf72 gene, meaning FTD-MND can exhibit familial patterns. It remains unclear whether FTD or ALS typically develops first.
ALS itself is not a dementia form but a rapidly progressing, terminal disease attacking neurons in the brain and spinal cord responsible for motor functions. ALS affects about thirty thousand Americans and proves fatal within two to five years as neuronal damage impairs movement, eating, and breathing. Symptoms include muscle weakness, twitching, cramping, stiffness, speech difficulties, swallowing troubles, and gradual paralysis. Approximately five thousand Americans die from ALS annually. Actor Eric Dane succumbed to the condition earlier this year at just fifty-three years old.
Progressive Supranuclear Palsy
Progressive supranuclear palsy (PSP) constitutes a rare, progressive brain disorder caused by toxic tangles of tau proteins within the brain, similar to Alzheimer's disease. These tangles damage nerve cells governing eye movements, walking, balance, and swallowing. PSP also induces dementia in about seventy percent of cases.
Damage primarily occurs within the brainstem and basal ganglia, regions regulating voluntary motor control and habit learning. Patients may experience loss of balance while walking, stiffness, awkward movements, slow or slurred speech, swallowing difficulties, sensitivity to bright light, sleep disturbances, impulsive behaviour, a surprised or frightened facial expression, and dizziness.
Also termed Steele-Richardson-Olszewski syndrome, PSP is frequently misdiagnosed as Parkinson's disease due to shared loss of movement control. The sole proven risk factor for PSP is age, with onset typically between sixty and seventy years. In rare instances, it can be inherited within families. Approximately thirty thousand Americans live with PSP, according to Cure PSP. No curative treatments exist, so medical management focuses on alleviating symptoms.
